Research Use Only · Not for Human Consumption · For Laboratory & Research Purposes
Home·Products·Tesamorelin
Tesamorelin

Tesamorelin

10 mg · 99.6% purity
$49.99Research Use Only

A 44-amino acid GHRH analog that stimulates pituitary gh secretion, studied for visceral adipose tissue reduction in clinical research.

Add to cart
Third-party testedSame-day shippingLyophilized · USA
Third-party tested
Independent HPLC identity & purity, 99%+, with a per-lot Certificate of Analysis.
Ships from the USA
Lyophilized and dispatched same-day from our U.S. facility.
Arrives safe or we replace it
Broken or damaged on arrival? Free replacement within 7 days. See our policy
Secure checkout
Encrypted checkout. Pay by crypto, Cash App, Zelle, or bank transfer.
Pairs Well

Frequently researched together

Compound Information

Technical specifications

Tesamorelin is a synthetic analogue of human Growth Hormone-Releasing Hormone (GHRH), a 44-amino acid hypothalamic peptide that stimulates pituitary somatotroph cells to secrete growth hormone (GH) via the GHRH receptor (GHRHR), a Gs-protein-coupled receptor. Unlike CJC-1295 (a truncated GHRH(1-29) analogue), tesamorelin retains the full 44-amino acid sequence of the endogenous hormone with an N-terminal trans-3-hexenoic acid modification that improves resistance to plasma dipeptidyl peptidase IV (DPP-IV) degradation. As a research compound, tesamorelin is used to study GHRH receptor binding kinetics, hypothalamic-pituitary GH axis signaling, and metabolic effects of GHRH receptor activation in preclinical and in vitro models.

Identity / Purity
99.6%
Format
Lyophilized powder
Size
10 mg
Lot
NLR-202606
Origin
Synthetic analogue of endogenous Growth Hormone-Releasing Hormone (GHRH), retaining the full 44-amino acid active sequence with a trans-3-hexenoic acid modification at the N-terminus
Storage
−20°C, sealed
Key facts
  • Retains full 44-amino acid sequence of endogenous human GHRH, unlike CJC-1295 which is based on the truncated GHRH(1-29) fragment
  • N-terminal trans-3-hexenoic acid modification increases resistance to DPP-IV proteolytic cleavage compared to native GHRH
  • GHRH receptor (GHRHR) is a class B G-protein-coupled receptor expressed predominantly on pituitary somatotrophs; activation stimulates cAMP–PKA signaling and GH release
  • Endogenous GHRH is secreted in pulsatile fashion from the arcuate nucleus of the hypothalamus and is rapidly degraded in plasma (t½ < 5 min for native GHRH)
  • Studied in published clinical research for effects on visceral adipose tissue in the context of metabolic research; that research used pharmaceutical-grade formulations under clinical trial conditions, which are distinct from this RUO compound
  • Lyophilized; reconstituted with bacteriostatic water for in vitro or animal model studies
  • For research use only — not for human or veterinary administration
⚠️
For Research Use Only

All products sold by Next Level Research LLC are intended for laboratory and research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. No therapeutic claims are made.